Description of Wedica
Wedica is a once-weekly dipeptidyl peptidase-IV (DPP-4) inhibitor. It controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones that play an important role in blood glucose regulation. The inhibition of DPP-4 increases insulin secretion depending on blood glucose concentration, thereby controlling blood glucose levels. Wedica is available in tablet form for oral administration.
|Generic||Brand Name||Formulation & Strength||Pack Size|
|Trelagliptin Succinate||Wedica||Tablet ( 50 mg )||2x10ís Alu-Alu|
Website Prescribing Information Order Now